The global single-cell multi-omics market size was valued at USD 6 billion in 2025 and is projected to grow from USD 7.14 billion in 2026 to USD 28.71 billion by 2034, registering a CAGR of 19% during the forecast period from 2026 to 2034. North America dominated the single-cell multi-omics market with a market share of 42.5% in 2025.
Single-cell multi-omics is an advanced research approach that studies multiple types of biological information, such as genes, RNA, proteins, and epigenetic changes, from a single cell at the same time. It helps researchers better understand cell function, disease progression, and treatment response. Demand is growing due to increasing investments in precision medicine, cancer research, drug discovery, and advanced genomic technologies.
Download a Free Sample To learn more about this report,
Increasing Integration of Multiple Omics Layers in Single-Cell Analysis
The single-cell multi-omics market is evolving through the increasing integration of genomic, transcriptomic, epigenomic, proteomic, and other molecular data from individual cells. Researchers are adopting multi-omics approaches to obtain a more comprehensive understanding of cellular function, heterogeneity, and biological mechanisms. The ability to examine multiple molecular characteristics simultaneously is supporting more detailed analysis across biomedical and life science research.
In March 2026, research organizations continued expanding the use of integrated single-cell multi-omics approaches to support more comprehensive cellular analysis.
Growing Adoption of High-Throughput and Automated Single-Cell Analysis Platforms
Technology developers are increasingly introducing automated workflows and high-throughput platforms designed to process larger numbers of individual cells efficiently. Improvements in sample preparation, microfluidics, sequencing workflows, and data-generation technologies are helping researchers conduct increasingly complex single-cell studies. The growing need to analyze large cell populations is supporting the adoption of scalable and automated multi-omics platforms.
In July 2026, life science technology providers continued advancing automated and high-throughput workflows for large-scale single-cell analysis.
Increasing Demand for Advanced Precision Medicine and Biomedical Research
Growing interest in understanding disease mechanisms at the cellular level is supporting demand for advanced single-cell multi-omics technologies. These approaches can help researchers investigate cellular differences associated with cancer, immune disorders, neurological diseases, and other complex conditions. The expanding focus on precision medicine and advanced biomedical research therefore remains a fundamental driver of the single-cell multi-omics market.
In April 2026, biomedical research organizations continued increasing investments in advanced technologies designed to support cellular-level disease research and precision medicine initiatives.
High Cost of Advanced Instruments, Sequencing, and Multi-Omics Workflows
Single-cell multi-omics studies can require specialized instruments, sequencing technologies, reagents, computational infrastructure, and highly trained personnel. The cost of conducting large-scale experiments can create financial barriers for smaller research institutions and laboratories. High technology and operational costs therefore remain an important restraint on broader adoption of single-cell multi-omics solutions.
In June 2026, research laboratories continued managing significant infrastructure and operational costs associated with advanced single-cell analysis workflows.
Expansion of Single-Cell Multi-Omics Through Clinical Research and Translational Medicine Infrastructure
The expansion of clinical research capabilities and translational medicine infrastructure is creating important opportunities for the adoption of single-cell multi-omics technologies. Hospitals, academic medical centers, research institutions, and specialized laboratories are increasingly developing capabilities to connect advanced biological research with clinical applications. Single-cell multi-omics can support detailed investigation of disease mechanisms, patient variability, and biological markers within translational research programs. The growing development of clinical research and translational medicine infrastructure therefore represents an important opportunity for the single-cell multi-omics market.
In August 2026, research institutions continued expanding advanced clinical research and translational medicine capabilities supporting more detailed cellular and molecular analysis.
Managing and Interpreting Complex Multi-Dimensional Biological Data
Single-cell multi-omics experiments can generate large and highly complex datasets involving multiple biological data types. Researchers must integrate, process, interpret, and validate this information while accounting for biological variability and technical differences between experimental workflows. Developing reliable analytical approaches and translating complex datasets into meaningful biological insights therefore remains a significant challenge for the single-cell multi-omics market.
In August 2026, research organizations continued strengthening computational and analytical capabilities for managing increasingly complex single-cell biological datasets.
Single-cell Genomics Segment Dominated the Market with 34.6% Share in 2025
The single-cell genomics segment dominated the global single-cell multi-omics market with a 34.6% share in 2025. Researchers widely use single-cell genomics to study genetic variations at the individual cell level, helping them better understand complex diseases and identify potential treatment targets. Increasing investment in precision medicine and genomics research continues to support the growth of this segment.
The single-cell transcriptomics and single-cell proteomics segments are also growing steadily. Transcriptomics helps researchers understand gene expression in individual cells, while proteomics provides detailed information about protein activity and cellular functions. Both technologies are becoming essential tools in cancer research, drug discovery, and disease diagnosis.
The single-cell metabolomics segment is expanding rapidly as scientists increasingly study cellular metabolism to understand disease progression and treatment response. Continuous improvements in sequencing technologies and analytical tools are expected to drive growth across all multi-omics approaches.
Request Customizationto receive a tailored report.
Oncology Segment Dominated the Market with 39.8% Share in 2025
The oncology segment dominated the global single-cell multi-omics market with a 39.8% share in 2025. Single-cell multi-omics technologies are helping researchers better understand tumor biology, identify cancer biomarkers, and develop more personalized treatment strategies. The increasing focus on precision oncology continues to make this the largest application segment.
The cell biology and immunology segments are also growing steadily as researchers use multi-omics tools to study cell behavior, immune responses, and disease mechanisms in greater detail. Neurology is also seeing increasing adoption as scientists investigate neurological disorders at the single-cell level to improve diagnosis and develop new therapies.
Growing research funding, advances in sequencing technologies, and the rising demand for personalized medicine are expected to support growth across all application areas.
Single Cell Analysis Segment Dominated the Market with 56.3% Share in 2025
The single cell analysis segment dominated the global single-cell multi-omics market with a 56.3% share in 2025. This technique allows researchers to examine the genetic, molecular, and functional characteristics of individual cells, providing deeper insights into disease development and biological processes. Its broad use in life science research continues to drive market growth.
The single cell isolation & dispensing segment is also growing steadily as accurate isolation of individual cells remains the first and most important step in single-cell analysis. Advances in microfluidics, automated platforms, and high-throughput technologies are making cell isolation faster and more reliable.
As laboratories continue to adopt integrated multi-omics workflows, demand for both isolation and analysis technologies is expected to increase over the forecast period.
Academic Institutes Segment Dominated the Market with 41.2% Share in 2025
The academic institutes segment dominated the global single-cell multi-omics market with a 41.2% share in 2025. Universities and research institutions are leading the adoption of single-cell multi-omics technologies as they conduct studies on genetics, cancer biology, immunology, and other complex diseases. Strong government funding and collaborative research projects continue to support this segment.
The pharmaceutical & biotech companies and contract research organizations (CROs) segments are also growing steadily. Pharmaceutical and biotechnology companies are using single-cell technologies to accelerate drug discovery and biomarker identification, while CROs are expanding their service offerings to support growing demand for advanced research and clinical studies.
Increasing collaboration between academic institutions, healthcare organizations, and the biopharmaceutical industry is expected to drive innovation and support long-term growth across all end-user segments.
Speak to an Analystto discuss market opportunities.
North America single-cell multi-omics market accounted for 42.5% of the global market, reaching USD 2.55 billion in 2025, and is projected to grow at a CAGR of 16.8% during the forecast period. The market is expanding rapidly due to increasing investments in precision medicine, rising genomics research, and growing demand for advanced single-cell analysis technologies. Strong research funding and the presence of leading biotechnology companies are also supporting market growth.
The U.S. market was valued at USD 2.17 billion in 2025, making it the largest contributor in North America. Growing investment in genomics research, increasing adoption of advanced sequencing technologies, and strong government support for precision medicine continue to drive market growth.
Canada's market reached USD 0.38 billion in 2025. Rising research funding, expanding biotechnology sector, and increasing collaboration between academic institutes and healthcare organizations continue to support steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe single-cell multi-omics market accounted for 27.3% of the global market, reaching USD 1.64 billion in 2025, and is expected to register a CAGR of 16.2% during the forecast period. Growing investment in life science research, increasing focus on personalized medicine, and rising adoption of advanced molecular analysis technologies are supporting market growth. Collaboration between research institutes and biotechnology companies is also helping the market expand.
Germany's market accounted for USD 0.48 billion in 2025. Strong biomedical research, increasing investment in genomics, and growing demand for advanced analytical technologies continue to support market growth.
The UK market was valued at USD 0.33 billion in 2025. Expanding genomics research programs, increasing government funding, and rising use of precision medicine continue to contribute to market growth.
Asia Pacific single-cell multi-omics market accounted for 21.4% of the global market, valued at USD 1.28 billion in 2025, and is projected to register a CAGR of 20.7% during the forecast period. Growing healthcare investments, expanding biotechnology research, and increasing adoption of advanced sequencing technologies are driving market growth across the region. Government support for life science innovation is also creating new opportunities.
Japan's market generated USD 0.23 billion in 2025. Strong research capabilities, increasing focus on precision medicine, and rising investment in biotechnology continue to support market growth.
China's market accounted for USD 0.67 billion in 2025, representing the largest share within Asia Pacific. Expanding genomics research, increasing biotechnology investments, and growing demand for advanced single-cell analysis technologies continue to drive market growth.
Latin America single-cell multi-omics market accounted for 5.1% of the global market, reaching USD 0.31 billion in 2025, and is projected to grow at a CAGR of 15.4% during the forecast period. Improving research infrastructure, increasing investment in biotechnology, and growing interest in precision medicine are supporting market growth across the region.
Brazil's market reached USD 0.16 billion in 2025. Rising investment in life science research, expanding academic collaborations, and increasing adoption of advanced molecular technologies continue to create growth opportunities.
Middle East & Africa single-cell multi-omics market accounted for 3.7% of the global market, totaling USD 0.22 billion in 2025, and is anticipated to grow at a CAGR of 14.8% during the forecast period. Growing investment in biomedical research, improving healthcare infrastructure, and increasing focus on precision medicine are supporting market growth across the region.
The UAE market was valued at USD 0.08 billion in 2025. Government investment in biotechnology, expanding research facilities, and increasing adoption of advanced genomic technologies continue to support market growth.
The global Single Cell Genomics market is highly competitive, driven by increasing demand for high-resolution genomic analysis, growing adoption of single-cell sequencing technologies, rising applications in cancer research and precision medicine, and expanding investments in advanced molecular biology platforms. Key players include Qiagen N.V., Takara Holdings Inc. Takara Bio Group, Thermo Fisher Scientific, Inc., 10x Genomics, Inc., Becton, Dickinson and Company, Illumina, Inc., Miltenyi Biotec B.V. & Co., Berkeley Lights Inc., BGI Genomics Co. Ltd., Dolomite Bio, Epicypher Inc., Fluidigm Corporation, Bio-Rad Laboratories, Inc., Mission Bio, Inc., and NanoString Technologies, Inc. Companies are focusing on single-cell sequencing, multi-omics analysis, high-throughput workflows, spatial biology, advanced sample preparation, automation, and bioinformatics solutions to strengthen their position in the global Single Cell Genomics market.
10x Genomics, Inc.: An Established Market Leader
10x Genomics, Inc. has strengthened its position through its portfolio of single-cell and spatial biology technologies that enable researchers to analyze genomic and cellular characteristics at high resolution. The company focuses on scalable single-cell analysis, high-throughput workflows, multi-omics applications, and advanced spatial analysis technologies for biomedical research. These capabilities support 10x Genomics, Inc.'s strong position in the global Single Cell Genomics market.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
CRISPR Gene Editing Market Size, Share, Growth, Analysis, 2034
Mass Spectrometry Market Size, Share, Growth, Analysis, 2034
Blood Testing Market Size, Share, Growth, Analysis, Report, 2034
3D Cell Culture Market Size, Share, Growth, Analysis, Report, 2034
3D Bioprinting Market Size, Share, Growth, Analysis, Report, 2034
United Kingdom Epigenetics Market Size, Trends, Top Share and Forecast to 2034
We are featured on:
sales@straitsresearch.com